Articles Tagged With:
-
Balloon Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
A multinational, prospective registry of balloon pulmonary angioplasty has shown that significant improvement in patients with chronic thromboembolic pulmonary hypertension can be accomplished with few complications and no periprocedural mortality.
-
Complications with the First Transcatheter Tricuspid Valve: Real-World Analysis
This review of complications seen in real-world practice with the Evoque transcatheter tricuspid valve highlights the need for careful patient selection and operator training with this technology.
-
Gepotidacin Tablets (Blujepa)
The U.S. Food and Drug Administration has approved gepotidacin, a first-in-class antibacterial medication for the treatment of uncomplicated urinary tract infections. It is the first new class of oral antibiotics approved in nearly 30 years.
-
Vasectomy Follow-Up Rates: How Good Are They?
In this retrospective cohort study of 2,567 patients at a single institution, 42.1% of men did not follow up at all after vasectomy for semen analysis. Of those with spermatozoa on the initial testing post-vasectomy, 43.3% of men failed to return for repeat testing.
-
Can Hyperemesis Gravidarum Be Prevented with Metformin?
Although differences were not statistically significant, women with pre-conceptional metformin exposure appeared to have lower rates of hyperemesis gravidarum and comparable nausea and vomiting symptom severity, suggesting a potential protective effect that warrants further investigation in larger, adequately powered studies.
-
What Are Period Pills?
In this national survey of almost 7,000 people aged 15 to 49 years who were assigned female sex at birth, conducted between December 2021 and January 2022, one-quarter of participants (24%; 95% confidence interval [CI], 22%, 25%) stated that they would personally use period pills and about half of the respondents (52%; 95% CI, 50%, 53%) were in favor of the availability of period pills.
-
Intrauterine Hemorrhage-Control Devices for Postpartum Hemorrhage
This multicenter, prospective, observational study comparing intrauterine balloon tamponade vs. vacuum-induced devices for postpartum hemorrhage demonstrated no difference in blood loss after device placement (median quantitative blood loss, 194 mL balloon vs. 240 mL vacuum; P = 0.40), need for blood transfusion (59.7% balloon vs. 50.0% vacuum; P = 0.08), need for more than three units of packed red blood cells (27.0% balloon vs. 24.9% vacuum; P = 0.53), or device failure (7.7% balloon vs. 8.5% vacuum; P = 0.70).
-
Maternal Deaths, Illness Rise in Some States as Policy Changes Affect Reproductive Care Access
New research shows that more pregnancy-capable people in the United States could have difficulty accessing contraceptives. Also, maternal deaths and morbidity are rising and could continue to rise because of additional policy changes.
-
OB/GYNs Can Help Patients Struggling with Mental Health Issues Related to Dobbs
OB/GYNs and reproductive healthcare providers can help young women cope with mental stress by providing support.
-
Research Shows Providers Experiencing Distress Post-Dobbs Decision
Researchers conducted in-depth interviews with clinicians — both in states with abortion bans and those without bans — about how changes in pregnancy care because of the Dobbs decision affected them.